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Tubulointerstitial Nephritis and
Uveitis Syndrome Associated with Renal Tryptase-
and Chymase-positive Mast Cell Infiltration
Yoshimi Sekiguchi, Michifumi Yamashita, Tomoko Sakamoto, Kyoichi Tashiro, Atsushi Kurusu, Yuichiro
Makita, Kunimi Maeda, Mitsumine Fukui, Chieko Hamada, Satoshi Horikoshi, Yasuhiko Tomino
We report the clinical course and immunohistochemical analysis of a patient who presented with tubulointerstitial
nephritis and uveitis syndrome (TINU syndrome). The patient, a 40-year-old woman, was referred to our
hospital with general fatigue and a slight fever from another hospital. Mast cells are closely related to the
development of renal interstitial fibrosis in patients with glomerulonephritis. To determine the role of mast
cells in renal interstitial injury in TINU patients, we performed immunohistochemical studies on renal biopsy
specimens using anti-human tryptase and anti-human chymase antibodies specific for mast cells. Double
immunostaining of tryptase and chymase was also performed in renal tissues. In double immunofluorescence,
cells with both chymase and tryptase (MCtc) were marked in the regions of interstitial fibrosis in this patient.
It appears that mast cells are one of the constitutive cells of interstitial fibrosis in patients with TINU syndrome.
[Hong Kong J Nephrol 2007;9(1):50–4]
Key words: chymase, interstitial nephritis, mast cell, TINU, tryptase
 !"#$%&'()$*== !=EqfkrF= !"#$%&'()*#+,-./0
 !"#$%&'=QM= !"#$%&'()*+",-./012.3456789:;
 !"#$%&'()*+,-./0123456789&:;<=>?@'()*3A
 !"#$%&'=E~åíáJÜìã~å=íêóéí~ëÉF= !"#$=E~åíáJÜìã~å=ÅÜóã~ëÉF !"#$
 !"#$%& '()*+,-./%&01+2345=qfkr= !"#$%&'()*
 !"#$%&'()*+,-./01234567"89:;<=5>3?@ABCDE
 !"#$%&'(=Ej`íÅF= !"#$%&'()*+,-./0123456=qfkr=
 !"#$%&'()*+,-./0123"456
INTRODUCTION
In 1975, Dobrin et al first reported tubulointerstitial
nephritis in two adolescent girls who demonstrated
granulomatous syndrome characterized by reversible
acute renal failure with eosinophilic interstitial nephritis,
bilateral anterior uveitis, bone marrow and lymph node
granulomas, hypergammaglobulinemia and an increase
in erythrocyte sedimentation rate (ESR) [1]. Both patients
showed improvement of renal function and bone marrow
granulomas. However, bone marrow granuloma and in-
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terstitial eosinophilia were not observed in many pre-
vious reports. This condition has been called tubulo-
interstitial nephritis and uveitis (TINU) syndrome
by Vanhaesebrouck et al [2]. Although the etiology of
TINU syndrome is unclear, it is assumed to be an
autoimmune disease [2]. Kondo et al found that both
mast cells and macrophages infiltrate into fibrotic
areas in TINU patients [3]. Repeated renal biopsies
showed that the number of infiltrating mast cells and
macrophages in the interstitium decreased with im-
provement of clinical symptoms and pathologic lesions.
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In this paper, we report the clinical course and
immunohistochemical approach in a 40-year-old
woman with a comparatively typical course of TINU
syndrome. Chemical mediators released from granules
in the mast cells, i.e. chymase and tryptase, may play
an important role in the development of renal interstitial
fibrosis [4–6]. For instance, the number of infiltrating
tryptase-positive mast cells was well correlated with
the degree of interstitial scarring [4] and creatinine
clearance [3]. Immunocytochemical studies have shown
the presence in the tissues of two mast cell phenotypes
distinguishable by their neutral protease content: the
MCt phenotype contains only tryptase and the MCtc
phenotype contains both tryptase and chymase [7].
To examine the role of mast cells (MCtc and MCt)
in renal fibrosis, we performed an immunohistochemical
study using anti-chymase and anti-tryptase antibodies
specific for mast cells in a patient with TINU syndrome.
CASE REPORT
In April 2002, a 40-year-old woman was referred to
the Juntendo University Hospital because of a 2-month
history of low grade fever and general fatigue. She was
first diagnosed as having a common cold and treated
with antibiotics and nonsteroidal anti-inflammatory
drugs. She had a history of allergic disease such as
bronchial asthma and nettle rash, and had an allergic
shock to the antibiotic Cephaclor.
On admission, her temperature was 37.2°C. Initial
laboratory findings showed mild renal insufficiency and
anemia. Serum creatinine was 2.27 mg/dL, serum urea
nitrogen was 23 mg/dL, hemoglobin was 9.1 g/dL,
hematocrit was 28.8%, and ESR was 102 mm/hour.
Total serum protein, albumin, immunoglobulins
complement and anti-nuclear antibody were normal.
Urinalysis showed glucosuria but no proteinuria,
while urinary excretion of β
2
-microglobulin was
29,750 ng/dL (Table). Blood gas analysis showed slight
acidosis (pH 7.339, HCO
3
 16.9, BE –8.9) caused by
tubular dysfunction. Ultrasonography and computed
tomography of the abdomen showed normal findings.
She was diagnosed with anterior uveitis by an
ophthalmologist, but the cause of the uveitis could not
be determined at that time. Toxoplasmosis, tuberculosis
and sarcoidosis were ruled out.
Percutaneous renal biopsy was performed on June
4, 2002. Marked mononuclear cell infiltration and
interstitial fibrosis were observed in the interstitium on
light microscopy. No glomerular or granulomatous
changes, or vascular alterations were observed (Figure
1). In immunofluorescence, there was no positive
staining of immunoglobulins (IgG, IgM, IgA) and
complement (C3, C4) in the renal tissues. Three-micron
sections from the formalin-fixed and paraffin-embedded
renal tissues were stained with human monoclonal
antibodies to human mast cell chymase (Serotec,
Raleigh, NC, USA) and human mast cell tryptase
(Dako, Glostrup, Denmark) using an autoclave-based
antigen retrieval technique and a modified peroxidase
anti-peroxidase method. Briefly, after autoclaving
(121°C, 5 minutes) 0.01 M citric buffer (pH 6.0) and
inactivating endogenous peroxidase 0.3% in H
2
O
2
 in
methanol, the renal sections were blocked with blocking
Table. Laboratory findings on admission and after treatment
Admission
After treatment
(1 yr after)
WBC (× 103/mm3) 10,500 5,500
RBC (× 106/mm3) 3.41 4.07
Hemoglobin (g/dL) 9.1 12.4
Hematocrit (%) 28.8 36.8
ESR (mm/hr) 102 18
CRP (mg/dL) 1.7 0.1
SUN (mg/dL) 23 14
Creatinine (mg/dL) 2.27 0.82
Total protein (g/dL) 9.1 8.0
IgG (mg/dL) 2,603 1,584
IgA (mg/dL) 612 452
IgM (mg/dL) 382 236
Complement level 67.4 42.3
Antinuclear antibodies × 20 × 20
Proteinuria Negative Negative
Glucosuria (++) Negative
Urinary β2-microglobulin (ng/dL) 29,750 1,040
N-acetyl-β-glucosaminidase (U/L) 7.4 2.1
Creatinine clearance (mL/min) 19 81
WBC = white blood cell count; RBC = red blood cell count;
ESR = erythrocyte sedimentation rate; CRP = C-reactive protein;
SUN = serum urea nitrogen.
Figure 1. Light microscopy of a renal biopsy specimen shows acute
tubulointerstitial reaction with edema and inflammatory cell
infiltration. Glomerulus shows no abnormalities (periodic acid
Schiff stain, 400×).
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solution (phosphate-buffered saline containing 2%
BSA, 2% fetal calf serum and 0.2% fish gelatin) for 30
minutes, followed by 1-hour incubation with antibody
to chymase or tryptase, both diluted 1:50 with blocking
solution. The sections were stained sequentially with
the human peroxidase-conjugated Envision System
(Dako Corp., Carpinteria, CA, USA), and developed
with diaminobenzidine to produce a brown color.
Nuclear counterstaining of the section was performed
with Mayer’s hematoxylin.
In addition, double immunostaining was performed
to detect human mast cell subtypes. Anti-human
chymase and anti-human tryptase antibodies labeled
with Alexa Fluor 488 and Alexa Fluor 568, respectively,
using Zenon Mouse IgG Labeling Kit (Molecular
Probes, Eugene, OR, USA) were used in this study.
The deparaffinized renal sections were incubated with
anti-human chymase antibody and then incubated
sequentially with anti-human tryptase antibody. After
washing with PBS three times, the sections were
mounted on slides with Perma FluorTM aqueous
mounting medium (Thermo Shandon, Pittsburgh, PA,
USA).
Serial sections showed positive staining for chymase
and tryptase with a similar pattern in the interstitial areas
(Figure 2). The double staining of chymase and tryptase
showed mostly MCtc in such areas (Figure 3). There
was no positive staining in the glomeruli.
We diagnosed TINU syndrome from the clinical and
histopathologic findings. Steroid pulse therapy with
methylprednisolone 500 mg for 3 days was started on
June 13, 2002. After pulse therapy, oral administration
of prednisolone was initiated at an initial dosage of
40 mg/day. One week after steroid therapy, serum
creatinine improved to 1.27 mg/dL. Prednisolone
dosage was then gradually tapered and discontinued
after 4 months. An anticoagulant (heparin) at 5,000
U/day was also administered with steroid therapy. One
month after the therapy, urinalysis and renal function
tests had almost normalized (Table). She was discharged
from our hospital on July 10, 2002. At that time, the
uveitis was also improved.
Figure 2. Immunostaining of: (A) tryptase; and (B) chymase in renal tissue. Serial sections show positive staining of chymase and
tryptase in a similar pattern. Mast cells are seen only in the interstitial area (200×).
Figure 3. Immunofluorescence of: (A) chymase; and (B) tryptase in the interstitial area of renal tissue. (C) Double immunofluorescence
of chymase and tryptase (MCtc) are dominant in the interstitial area. Negative staining in the glomerulus (100×).
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DISCUSSION
In this patient, there were no granulomatous changes
in renal tissues although interstitial nephritis and
uveitis were observed. All reported adult patients
presented with body weight loss, elevated ESR and
anemia ,  and 80% of  pat ients  d id  not  have
hypergammaglobulinemia, which is a consistent
feature in adolescents. White blood cell count, C-
reactive protein and ESR were elevated and urinary
β
2
-microglobulin was also elevated. Our patient had
typical findings of TINU syndrome with interstitial
lymphocyte infiltration and tubular atrophy without
granulomas. Most reported cases showed completely
normal glomeruli as in our patient. Large numbers of
mast cells, which have a potential for serious disease
progression, have been observed in patients with
glomerulonephritis such as focal segmental glomerular
sclerosis, membranoproliferative glomerulonephritis,
diabetic nephropathy, and IgA nephropathy [8,9]. On
the other hand, patients with minimal change nephrotic
syndrome with normal renal function had small
numbers of mast cells in renal tissues [8]. These
reports suggest that mast cells in the tubulointerstitium
may play an important role in tubulointerstitial
fibrosis. Generally, tissue fibrosis is based on the
balance between production and degradation of the
extracellular matrix. Recently, Okazaki et al reported
that the number of mast cells was correlated with
hydroxyproline content in experimentally-induced
fibrosis in rat lung and liver [10]. It was suggested
that mast cells may contribute mainly to the
degradation of the extracellular matrix. Therefore, it
is possible that these cells may regulate extracellular
matrix metabolism in the kidneys. Mast cell granule
synthesis has been reported to be a mitogenic factor
for cultured fibroblasts and enhanced collagen
synthesis [11,12]. Ehara and Shigematsu found, by
microscopic observation, that tryptase-positive mast
cells were associated with fibroblast-like cells
cooperating with lymphocytes and macrophages in
the fibrous interstitium of patients with IgA
nephropathy [5]. Moreover, mast cells have been
shown to produce cytokines and growth factors that
may contribute to fibrosis, such as tumor necrosis
factor-α and transforming growth factor-β.
Immunocytochemical studies have shown the
presence within the tissues of two mast cell phenotypes
distinguishable by their neutral protease content; the
MCt phenotype contains only tryptase and the MCtc
phenotype contains both tryptase and chymase. MCt
phenotypes appear to be “immune system-related” mast
cells with a primary role in host defense. On the other
hand, MCtc phenotypes appear to be “non-immune
system-related” mast cells, which have functions of
angiogenesis and tissue remodeling rather than
immunologic protection. The mast cell phenotype in
patients with IgA nephropathy or diabetic nephropathy
is mainly MCtc [5]. Kurusu et al investigated whether
mast cells in the tubulointerstitium actively contribute
to the development of tubulointerstitial fibrosis in
patients with IgA nephropathy [13]. These cells were
observed in the tubulointerstitium, including the
perivascular and periglomerular areas, but not in the
glomeruli of patients with IgA nephropathy. There was
a significant correlation between the number of mast
cells per unit area in the whole tubulointerstitium and
the degree of tubulointerstitial fibrosis or level of
urinary protein excretion, but not with the level of
urinary β
2
-microglobulin. These results suggest that the
number of mast cells in the tubulointerstitium may
influence the prognosis in patients with IgA
nephropathy [13]. Patients with rapidly progressive
glomerulonephritis or renal amyloidosis had the MCt
rather than the MCtc phenotype [14].
In TINU syndrome, the degree of renal insufficien-
cy is closely correlated with the severity of tubu-
lointerstitial fibrosis and the number of mast cells.
Kondo et al suggested that mast cells, in addition to
macrophages, might play an important role in the
development of interstitial injury in TINU syndrome
because the degree of renal interstitial lesions appears
to be related to the number of these cells [4]. They also
suggested that mast cells showed a stronger tendency
to infiltrate the fibrotic areas than macrophages. To date,
there have been no studies staining both tryptase and
chymase in TINU syndrome patients. We examined the
localization of mast cells using anti-human tryptase and
anti-human chymase antibodies specific for mast cells
in a patient with TINU syndrome. We also performed
double immunostaining using tryptase and chymase to
determine which phenotype is dominant. In this case,
it appeared that most mast cells that infiltrated the
fibrotic areas are MCtc. It is postulated that MCtc is
one of the constitutive cells of interstitial fibrosis in
patients with TINU syndrome.
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